Composite results show that daily oral intake of mushroom beta-glucan in tumor-bearing mice can lower the amounts of M-CSF gene expression in the lungs but does not affect the amounts of IL-12, GM-CSF, IFN-γ, IL-6, IL-10, COX-2, and TGF-β in the lungs. Here, CSF2 is linked to neoplasm.